Showing results (1171-1180 of 2,468) with videos related to
Sort By:
Pageof 247
Cancer Treatment Reviews|March 7, 2024
Cancer genetic counselling for hereditary breast cancer in the era of precision oncologyM Pensabene, A Calabrese, C von Arx, et al.Cancer Treatment Reviews|July 6, 2024
Extracellular vesicles and the "six Rs" in radiotherapyIsabel Ripoll-Viladomiu, Adriele Prina-Mello, Dania Movia, et al.Cancer Treatment Reviews|April 4, 2024
Intermittent fasting and its impact on toxicities, symptoms and quality of life in patients on active cancer treatmentRobert Li Sucholeiki, Casey L Propst, David S Hong, et al.Cancer Treatment Reviews|September 13, 2024
Bone complications of cancer treatmentNanxi Zhu, Hao Ni, Shengzhao Guo, et al.Cancer Treatment Reviews|September 18, 2024
Oral SERDs changing the scenery in hormone receptor positive breast cancer, a comprehensive reviewMathilde Gheysen, Kevin Punie, Hans Wildiers, et al.Cancer Treatment Reviews|October 4, 2024
Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic developmentCarla Corvaja, Antonio Passaro, Ilaria Attili, et al.Cancer Treatment Reviews|August 6, 2024
Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategiesJi-Hoon LeeCancer Treatment Reviews|October 23, 2024
Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapySimone Ielpo, Francesca Barberini, Farnaz Dabbagh Moghaddam, et al.Cancer Treatment Reviews|October 23, 2024
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectivesClaudia Parisi, Pamela Abdayem, Marco Tagliamento, et al.Cancer Treatment Reviews|September 21, 2024
Induction treatment with FOLFIRINOX or oxaliplatin-based doublet followed by long-course chemoradiotherapy and surgery in locally advanced rectal cancer. A systematic review and pooled analysis from phase II and III trialsRoberto Moretto, Guglielmo Vetere, Martina Carullo, et al.Pageof 247